Skip to content
Recall Observatory FDA recall evidence

Drug product

NAD+ (Nicotinamide adenine dinucleotide) for Injection, a) 100 mg/mL b) 200 mg/mL, 10 mL multi-dose amber vials, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692.

D-0094-2026

July 30, 2025

Class I

Product summary

Firm
GenoGenix LLC
Event
Event 97369
Status
Ongoing
Classification
Class I
Quantity
Unavailable
Official record key
drug-enforcement:D-0094-2026

Official wording

Reason: Microbial Contamination of Sterile Products: elevated endotoxin levels

Code information: Lot#: GG121624-023, within expiry

Distribution pattern: US Nationwide.

Derived failure modes

  • Microbial contamination

    reason.microbial_contamination · v1.0.0

    Microbial Contamination